Literature DB >> 23937626

Paraneoplastic neurological syndromes.

F Leypoldt1, K-P Wandinger.   

Abstract

Paraneoplastic neurological syndromes are immune-mediated erroneous attacks on the central or peripheral nervous systems, or both, directed originally against the tumour itself. They have been known for more than 40 years, but recently the discovery of new subgroups of paraneoplastic encephalitis syndromes with a remarkably good response to immune therapy has ignited new clinical and scientific interest. Knowledge of these subgroups and their associated autoantibodies is important in therapeutic decision-making. However, the abundance of new autoantibodies and syndromes can be confusing. This review paper summarizes current knowledge and new developments in the field of paraneoplastic neurological syndromes, their classification, pathophysiology and treatment.
© 2013 British Society for Immunology.

Entities:  

Keywords:  anti-NMDA receptor encephalitis; limbic encephalitis; paraneoplastic antibodies; paraneoplastic syndromes

Mesh:

Year:  2014        PMID: 23937626      PMCID: PMC3927895          DOI: 10.1111/cei.12185

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  84 in total

1.  Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.

Authors:  F Graus; F Keime-Guibert; R Reñe; B Benyahia; T Ribalta; C Ascaso; G Escaramis; J Y Delattre
Journal:  Brain       Date:  2001-06       Impact factor: 13.501

2.  Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

Authors:  W P Mason; F Graus; B Lang; J Honnorat; J Y Delattre; F Valldeoriola; J C Antoine; M K Rosenblum; M R Rosenfeld; J Newsom-Davis; J B Posner; J Dalmau
Journal:  Brain       Date:  1997-08       Impact factor: 13.501

Review 3.  Paraneoplastic syndromes involving the nervous system.

Authors:  Robert B Darnell; Jerome B Posner
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

4.  Response to rituximab in 3 children with opsoclonus-myoclonus syndrome resistant to conventional treatments.

Authors:  Teresa Battaglia; Elisa De Grandis; Marisol Mirabelli-Badenier; Luca Boeri; Guido Morcaldi; Paola Barabino; Chiara Intra; Francesca Naselli; Vito Pistoia; Edvige Veneselli; Massimo Conte
Journal:  Eur J Paediatr Neurol       Date:  2011-07-06       Impact factor: 3.140

5.  Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics.

Authors:  H R Lee; V A Lennon; M Camilleri; C M Prather
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

6.  GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders.

Authors:  A Boronat; L Sabater; A Saiz; J Dalmau; F Graus
Journal:  Neurology       Date:  2011-03-01       Impact factor: 9.910

7.  Progressive necrotic myelopathy: clinical course in 9 patients.

Authors:  J D Katz; A H Ropper
Journal:  Arch Neurol       Date:  2000-03

8.  Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.

Authors:  Maarten J Titulaer; Paul Maddison; Jacob K Sont; Paul W Wirtz; David Hilton-Jones; Rinse Klooster; Nick Willcox; Marko Potman; Peter A E Sillevis Smitt; Jan B M Kuks; Bart O Roep; Angela Vincent; Silvère M van der Maarel; J Gert van Dijk; Bethan Lang; Jan J G M Verschuuren
Journal:  J Clin Oncol       Date:  2011-01-18       Impact factor: 44.544

9.  Onconeural antibodies in sera from patients with various types of tumours.

Authors:  Sissel Evy Monstad; Anette Knudsen; Helga B Salvesen; Jan H Aarseth; Christian A Vedeler
Journal:  Cancer Immunol Immunother       Date:  2009-03-18       Impact factor: 6.968

10.  Clinical analysis of anti-Ma2-associated encephalitis.

Authors:  Josep Dalmau; Francesc Graus; Alberto Villarejo; Jerome B Posner; Deborah Blumenthal; Brian Thiessen; Albert Saiz; Patricio Meneses; Myrna R Rosenfeld
Journal:  Brain       Date:  2004-06-23       Impact factor: 13.501

View more
  37 in total

1.  Neuroinflammation of the central and peripheral nervous system: an update.

Authors:  O Stüve; U Zettl
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

Review 2.  Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury.

Authors:  Alan I Faden; Junfang Wu; Bogdan A Stoica; David J Loane
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

3.  Clinical Reasoning: Stepwise paralysis in a patient with adenocarcinoma of lung.

Authors:  Julio C Furlan; Lawrence R Robinson; Brian J Murray
Journal:  Neurology       Date:  2016-03-22       Impact factor: 9.910

4.  Paraneoplastic Atypical Parkinsonism with Anti-CRMP5 Antibodies and Severe Caudate and Putaminal Hypometabolism on 18-Fluorodeoxyglucose Positron Emission Tomography of the Brain.

Authors:  Siew Mei Yap; Tim Lynch; Peter MacMahon; Brian Murray
Journal:  Mov Disord Clin Pract       Date:  2016-06-06

5.  [Neurological symptoms in a patient on anti-TNF therapy, methotrexate and prednisolone for rheumatoid arthritis].

Authors:  M Bach; S Schob; C Baerwald
Journal:  Internist (Berl)       Date:  2020-03       Impact factor: 0.743

6.  Antibodies against neural antigens in patients with acute stroke: joint results of three independent cohort studies.

Authors:  Georg Royl; Tsafack Judicael Fokou; Rittika Chunder; Rakad Isa; Thomas F Münte; Klaus-Peter Wandinger; Markus Schwaninger; Oliver Herrmann; José Manuel Valdueza; Jan Brocke; Martin Willkomm; Dietrich Willemsen; Gerd U Auffarth; Swantje Mindorf; Britta Brix; Angel Chamorro; Anna Planas; Xabier Urra
Journal:  J Neurol       Date:  2019-07-29       Impact factor: 4.849

7.  Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.

Authors:  Timotej Petrijan; Marija Menih
Journal:  Cerebellum       Date:  2017-08       Impact factor: 3.847

Review 8.  Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?

Authors:  Alan I Faden; David J Loane
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

9.  Whole Genome-Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non-Small-Cell Lung Cancer.

Authors:  Yuanqing Yan; Nan Sun; Hong Wang; Makoto Kobayashi; Jon J Ladd; James P Long; Ken C Lo; Jigar Patel; Eric Sullivan; Thomas Albert; Gary E Goodman; Kim-Anh Do; Samir M Hanash
Journal:  Cancer Res       Date:  2019-02-05       Impact factor: 12.701

10.  Paraneoplastic cerebellar degeneration in a patient with anaplastic non-Hodgkin's lymphoma.

Authors:  Nadir Khan
Journal:  BMJ Case Rep       Date:  2018-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.